MASOLA, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 2.062
EU - Europa 1.971
AS - Asia 1.299
SA - Sud America 181
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.545
Nazione #
US - Stati Uniti d'America 2.028
RU - Federazione Russa 771
SG - Singapore 527
GB - Regno Unito 409
CN - Cina 377
IT - Italia 218
BR - Brasile 138
SE - Svezia 127
VN - Vietnam 126
FR - Francia 116
HK - Hong Kong 98
IE - Irlanda 87
FI - Finlandia 82
DE - Germania 80
KR - Corea 41
AR - Argentina 23
UA - Ucraina 23
BD - Bangladesh 22
IN - India 20
ID - Indonesia 18
BE - Belgio 13
CA - Canada 13
AT - Austria 11
MX - Messico 10
TR - Turchia 10
ZA - Sudafrica 9
IL - Israele 7
NG - Nigeria 7
JP - Giappone 6
CH - Svizzera 5
EC - Ecuador 5
ES - Italia 5
IQ - Iraq 5
RO - Romania 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
MA - Marocco 4
PK - Pakistan 4
PL - Polonia 4
PS - Palestinian Territory 4
CL - Cile 3
LB - Libano 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
NL - Olanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.545
Città #
Southend 355
Moscow 274
Chandler 271
Singapore 271
Ashburn 237
San Jose 174
Jacksonville 137
Woodbridge 130
Dallas 113
Ann Arbor 96
Hong Kong 96
Dublin 85
Beijing 80
The Dalles 55
Verona 55
Council Bluffs 52
Houston 47
New York 41
Wilmington 41
Lawrence 37
Princeton 37
Ho Chi Minh City 29
Los Angeles 29
Nanjing 22
Redondo Beach 21
Columbus 20
Dong Ket 20
Shenyang 20
Helsinki 19
Jinan 19
Hanoi 18
Redmond 17
Buffalo 16
São Paulo 16
Munich 14
Brussels 13
Tianjin 13
Santa Clara 12
Jakarta 11
Milan 11
Seattle 11
Hebei 10
Orem 10
Vienna 10
Boardman 9
Taizhou 9
Brooklyn 8
Denver 8
Guangzhou 8
Jiaxing 8
Ningbo 8
Chicago 7
Frankfurt am Main 7
Johannesburg 7
Nanchang 7
Padova 7
Phoenix 7
Rome 7
Montreal 6
San Francisco 6
Stockholm 6
Tokyo 6
Turku 6
Zhengzhou 6
Abuja 5
Chennai 5
Da Nang 5
Fairfield 5
Hangzhou 5
Istanbul 5
Shanghai 5
Sindelfingen 5
Auburn Hills 4
Barnet 4
Catanzaro 4
Changsha 4
Genova 4
Hải Dương 4
Kochi 4
Lancaster 4
London 4
Norwalk 4
Querétaro 4
Quito 4
Rio de Janeiro 4
Seoul 4
Toronto 4
Warsaw 4
Atlanta 3
Biên Hòa 3
Bologna 3
Buenos Aires 3
Cabo Frio 3
Campinas 3
Conselheiro Lafaiete 3
Detroit 3
Florence 3
Fuzhou 3
Governador Valadares 3
Haikou 3
Totale 3.348
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 260
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 259
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 200
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 186
mTOR inhibitors and renal allograft: Yin and Yang. 185
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 184
Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats. 181
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 180
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 179
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 179
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 171
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 165
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 165
Sulodexide and glycosaminoglycans in the progression of renal disease. 162
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 162
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 161
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 153
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 148
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 148
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 147
Heparanase as a target in cancer therapy. 146
Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells 145
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells. 144
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 144
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 144
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 138
Heparanase: another renal player controlled by vitamin d. 136
Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion 135
L: -citrulline Prevents Alveolar and Vascular Derangement in a Rat Model of Moderate Hyperoxia-induced Lung Injury. 130
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 129
Endothelial Glycocalyx as a Regulator of Fibrotic Processes 116
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. 110
LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase 105
The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells 95
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. 93
Impact of heparanase on renal fibrosis. 86
Role of Heparanase in Tumor Progression: Molecular Aspects and Therapeutic Options 71
Totale 5.642
Categoria #
all - tutte 18.704
article - articoli 17.994
book - libri 0
conference - conferenze 710
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/2022280 26 48 4 54 4 9 10 22 7 8 17 71
2022/2023673 51 92 65 103 64 137 15 39 80 4 16 7
2023/2024255 16 25 25 12 32 42 9 19 1 17 45 12
2024/2025740 45 43 30 131 33 30 47 35 118 30 67 131
2025/20262.243 162 95 110 372 619 163 218 121 130 153 35 65
Totale 5.642